Purslane-induced oxalate nephropathy: case report and literature review.
Acute kidney injury
Case report
Hyperoxaluria
Oxalate nephropathy
Portulaca oleracea
Purslane
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
13 07 2023
13 07 2023
Historique:
received:
24
09
2022
accepted:
08
06
2023
medline:
17
7
2023
pubmed:
14
7
2023
entrez:
13
7
2023
Statut:
epublish
Résumé
The kidney is particularly vulnerable to toxins due to its abundant blood supply, active tubular reabsorption, and medullary interstitial concentration. Currently, calcium phosphate-induced and calcium oxalate-induced nephropathies are the most common crystalline nephropathies. Hyperoxaluria may lead to kidney stones and progressive kidney disease due to calcium oxalate deposition leading to oxalate nephropathy. Hyperoxaluria can be primary or secondary. Primary hyperoxaluria is an autosomal recessive disease that usually develops in childhood, whereas secondary hyperoxaluria is observed following excessive oxalate intake or reduced excretion, with no difference in age of onset. Oxalate nephropathy may be overlooked, and the diagnosis is often delayed or missed owning to the physician's inadequate awareness of its etiology and pathogenesis. Herein, we discuss the pathogenesis of hyperoxaluria with two case reports, and our report may be helpful to make appropriate treatment plans in clinical settings in the future. We report two cases of acute kidney injury, which were considered to be due to oxalate nephropathy in the setting of purslane (portulaca oleracea) ingestion. The two patients were elderly and presented with oliguria, nausea, vomiting, and clinical manifestations of acute kidney injury requiring renal replacement therapy. One patient underwent an ultrasound-guided renal biopsy, which showed acute tubulointerstitial injury and partial tubular oxalate deposition. Both patients underwent hemodialysis and were discharged following improvement in creatinine levels. Our report illustrates two cases of acute oxalate nephropathy in the setting of high dietary consumption of purslane. If a renal biopsy shows calcium oxalate crystals and acute tubular injury, oxalate nephropathy should be considered and the secondary causes of hyperoxaluria should be eliminated.
Sections du résumé
BACKGROUND
The kidney is particularly vulnerable to toxins due to its abundant blood supply, active tubular reabsorption, and medullary interstitial concentration. Currently, calcium phosphate-induced and calcium oxalate-induced nephropathies are the most common crystalline nephropathies. Hyperoxaluria may lead to kidney stones and progressive kidney disease due to calcium oxalate deposition leading to oxalate nephropathy. Hyperoxaluria can be primary or secondary. Primary hyperoxaluria is an autosomal recessive disease that usually develops in childhood, whereas secondary hyperoxaluria is observed following excessive oxalate intake or reduced excretion, with no difference in age of onset. Oxalate nephropathy may be overlooked, and the diagnosis is often delayed or missed owning to the physician's inadequate awareness of its etiology and pathogenesis. Herein, we discuss the pathogenesis of hyperoxaluria with two case reports, and our report may be helpful to make appropriate treatment plans in clinical settings in the future.
CASE PRESENTATION
We report two cases of acute kidney injury, which were considered to be due to oxalate nephropathy in the setting of purslane (portulaca oleracea) ingestion. The two patients were elderly and presented with oliguria, nausea, vomiting, and clinical manifestations of acute kidney injury requiring renal replacement therapy. One patient underwent an ultrasound-guided renal biopsy, which showed acute tubulointerstitial injury and partial tubular oxalate deposition. Both patients underwent hemodialysis and were discharged following improvement in creatinine levels.
CONCLUSIONS
Our report illustrates two cases of acute oxalate nephropathy in the setting of high dietary consumption of purslane. If a renal biopsy shows calcium oxalate crystals and acute tubular injury, oxalate nephropathy should be considered and the secondary causes of hyperoxaluria should be eliminated.
Identifiants
pubmed: 37443012
doi: 10.1186/s12882-023-03236-9
pii: 10.1186/s12882-023-03236-9
pmc: PMC10347717
doi:
Substances chimiques
Calcium Oxalate
2612HC57YE
Oxalates
0
Types de publication
Review
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
207Informations de copyright
© 2023. The Author(s).
Références
Drugs. 2022 Jul;82(10):1077-1094
pubmed: 35779234
J Urol. 2010 Jun;183(6):2244-8
pubmed: 20400141
Clin J Am Soc Nephrol. 2011 Aug;6(8):1895-902
pubmed: 21737848
Nephrol Dial Transplant. 2022 Apr 25;37(5):869-875
pubmed: 33543760
Clin J Am Soc Nephrol. 2021 Mar 8;16(3):487-495
pubmed: 32900691
Kidney Int Rep. 2020 Jul 02;5(9):1503-1509
pubmed: 32954074
BMJ Case Rep. 2019 Sep 16;12(9):
pubmed: 31527218
Kidney Int. 2001 Jan;59(1):270-6
pubmed: 11135080
Am J Med. 1980 Oct;69(4):628-32
pubmed: 7424952
Kidney Int. 2001 Jan;59(1):31-6
pubmed: 11135054
Kidney Int. 2009 Jun;75(12):1264-1271
pubmed: 19225556
Am J Physiol Renal Physiol. 2019 Mar 1;316(3):F409-F413
pubmed: 30566003
Nephrol Dial Transplant. 2019 Jun 1;34(6):908-914
pubmed: 30169827
Transpl Immunol. 2022 Jun;72:101589
pubmed: 35346825
Urology. 2009 Mar;73(3):484-9
pubmed: 19118878
Sci Rep. 2017 Aug 3;7(1):7250
pubmed: 28775336
J Med Case Rep. 2021 Mar 8;15(1):106
pubmed: 33678172
Urolithiasis. 2020 Oct;48(5):377-384
pubmed: 32719990
Am J Kidney Dis. 2019 Feb;73(2):258-272
pubmed: 30249419
N Engl J Med. 2013 Aug 15;369(7):649-58
pubmed: 23944302
Nutrients. 2020 Sep 02;12(9):
pubmed: 32887293
Nat Rev Nephrol. 2012 Jun 12;8(8):467-75
pubmed: 22688746
Kidney Int Rep. 2020 Sep 02;5(11):2013-2020
pubmed: 33163722
Am J Kidney Dis. 2022 May;79(5):717-727
pubmed: 34508834
J Ethnopharmacol. 2017 Jun 9;205:158-172
pubmed: 28495602
Heliyon. 2021 Dec 27;8(1):e08669
pubmed: 35028454
Curr Opin Urol. 2020 Mar;30(2):171-176
pubmed: 31895888
Semin Diagn Pathol. 2020 May;37(3):135-142
pubmed: 32178905
Urolithiasis. 2016 Feb;44(1):27-32
pubmed: 26614109
Clin J Am Soc Nephrol. 2008 Nov;3(6):1676-83
pubmed: 18701613
Contrib Nephrol. 2021;199:143-154
pubmed: 34343992
Nutrients. 2020 Dec 28;13(1):
pubmed: 33379176
Am J Kidney Dis. 2004 Jul;44(1):1-11
pubmed: 15211432
World J Nephrol. 2014 Nov 6;3(4):122-42
pubmed: 25374807
Int J Surg. 2016 Dec;36(Pt D):705-712
pubmed: 27865972
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9425-30
pubmed: 11459928
J Gastroenterol Hepatol. 2004 Dec;19(12):1403-9
pubmed: 15610315
Am J Kidney Dis. 2007 Jan;49(1):153-7
pubmed: 17185156
Clin Nephrol. 2017 Dec;88(12):354-358
pubmed: 29092737
ScientificWorldJournal. 2014 Feb 10;2014:951019
pubmed: 24683365
Urolithiasis. 2013 Jun;41(3):187-96
pubmed: 23632911
Kidney Int. 2016 Sep;90(3):525-39
pubmed: 27262364
J Am Soc Nephrol. 2015 Oct;26(10):2559-70
pubmed: 25644115
Plant Foods Hum Nutr. 1994 Jan;45(1):1-9
pubmed: 8146099
Kidney Int. 2013 Nov;84(5):895-901
pubmed: 23739234